Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Mar-24 4:26 PM View:  | Tetrault Lynn A. Director | Neogenomics Inc. (NEO) | 04-Mar-24 | Sale | 6,112 | $15.97 | $97,578.70 | (11%) 56.17K to 50.06K | |
| 20-Feb-24 4:32 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 15-Feb-24 | Sale | 2,587 | $14.96 | $38,712.90 | (7%) 37.45K to 34.87K | |
| 03-Jan-24 5:28 PM View: | Harris Melody President, Enterprise Ops | Neogenomics Inc. (NEO) | 01-Jan-24 | Payment of Exercise | 7,123 | -- | -- | (6%) 110.08K to 102.95K | |
| 11-Dec-23 7:54 PM View: | Sherman Jeffrey Scott Chief Financial Officer | Neogenomics Inc. (NEO) | 07-Dec-23 | Payment of Exercise | 8,147 | -- | -- | (6%) 133.81K to 125.66K | |
| 05-Dec-23 4:49 PM View: | Stone Warren President, Clinical Services | Neogenomics Inc. (NEO) | 01-Dec-23 | Payment of Exercise | 5,431 | -- | -- | (6%) 89.21K to 83.78K | |
| 20-Nov-23 4:33 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 17-Nov-23 | Sale | 2,669 | $18.39 | $49,082.90 | (7%) 39.81K to 37.14K | |
| 03-Oct-23 10:00 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 30-Sep-23 | Payment of Exercise | 14 | -- | -- | (< 1%) 39.51K to 39.5K | |
| 05-Sep-23 5:27 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 01-Sep-23 | Payment of Exercise | 1,666 | -- | -- | (4%) 41.08K to 39.41K | |
| 01-Aug-23 5:26 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 01-Aug-23 | Payment of Exercise | 14 | -- | -- | (< 1%) 40.99K to 40.98K | |
| 02-Jun-23 6:01 PM View: | Sikri Vishal President Advanced Diagnostics | Neogenomics Inc. (NEO) | 01-Jun-23 | Payment of Exercise | 21,406 | -- | -- | (14%) 149.12K to 127.72K | |
| 24-May-23 5:29 PM View: | Tetrault Lynn A. Director | Neogenomics Inc. (NEO) | 22-May-23 | Option Exercise | 1,507 | $11.60 | $17,481.20 | 3% 54.67K to 56.17K | |
| 03-May-23 4:59 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 01-May-23 | Payment of Exercise | 662 | -- | -- | (2%) 41.36K to 40.69K | |
| 04-Apr-23 5:04 PM View: | Kulkarni Shashikant Chief Scientific Officer | Neogenomics Inc. (NEO) | 01-Apr-23 | Payment of Exercise | 3,759 | -- | -- | (4%) 86.43K to 82.67K | |
| 03-Mar-23 5:34 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 02-Mar-23 | Payment of Exercise | 117 | -- | -- | (< 1%) 29.88K to 29.77K | |
| 03-Mar-23 5:34 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 01-Mar-23 | Payment of Exercise | 880 | -- | -- | (3%) 30.76K to 29.88K | |
| 04-Jan-23 5:39 PM View: | Harris Melody President, Enterprise Ops | Neogenomics Inc. (NEO) | 01-Jan-23 | Grant | 108,225 | -- | -- | 100% 0 to 108.22K | |
| 01-Feb-23 10:00 PM View: | Sikri Vishal President, Pharma Services | Neogenomics Inc. (NEO) | 31-Dec-22 | Acquisition (small) | 225 | $7.04 | $1,584.00 | < 1% 148.46K to 148.68K | |
| 04-Jan-23 5:40 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 31-Dec-22 | Payment of Exercise | 959 | -- | -- | (3%) 31.72K to 30.76K | |
| 07-Dec-22 8:47 PM View: | Sherman Jeffrey Scott Chief Financial Officer | Neogenomics Inc. (NEO) | 05-Dec-22 | Grant | 133,809 | -- | -- | 100% 0 to 133.81K | |
| 05-Dec-22 9:23 PM View: | Stone Warren President, Clinical Services | Neogenomics Inc. (NEO) | 01-Dec-22 | Grant | 89,206 | -- | -- | 100% 0 to 89.21K | |
| 07-Nov-22 5:13 PM View: | Perez David Brian Director | Neogenomics Inc. (NEO) | 03-Nov-22 | Grant | 10,300 | -- | -- | 100% 0 to 10.3K | |
| 03-Nov-22 5:16 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 01-Nov-22 | Grant | 13,141 | -- | -- | 71% 18.58K to 31.72K | |
| 17-Aug-22 7:13 PM View: | Smith Christopher M Chief Executive Officer | Neogenomics Inc. (NEO) | 15-Aug-22 | Grant | 602,219 | -- | -- | 100% 0 to 602.22K | |
| 03-Aug-22 5:44 PM View: | Kulkarni Shashikant President of Lab Operations | Neogenomics Inc. (NEO) | 01-Aug-22 | Grant | 24,704 | -- | -- | 60% 41.15K to 65.86K | |
| 03-Aug-22 5:45 PM View: | Sholehvar David President, Clinical Services | Neogenomics Inc. (NEO) | 01-Aug-22 | Grant | 12,352 | -- | -- | 40% 30.86K to 43.22K | |
| 24-Jun-22 5:07 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 22-Jun-22 | Payment of Exercise | 57 | -- | -- | (< 1%) 18.64K to 18.58K | |
| 14-Jun-22 8:43 PM View: | Kanovsky Stephen M Director | Neogenomics Inc. (NEO) | 10-Jun-22 | Grant | 15,556 | -- | -- | 169% 9.2K to 24.75K | |
| 14-Jun-22 8:41 PM View: | Daly David Director | Neogenomics Inc. (NEO) | 10-Jun-22 | Grant | 15,556 | -- | -- | 958% 1.62K to 17.18K | |
| 14-Jun-22 8:43 PM View: | Kelly Michael Aaron Director | Neogenomics Inc. (NEO) | 10-Jun-22 | Grant | 15,556 | -- | -- | 320% 4.86K to 20.42K | |
| 14-Jun-22 8:42 PM View: | Stahler Rachel A Director | Neogenomics Inc. (NEO) | 10-Jun-22 | Grant | 15,556 | -- | -- | 269% 5.78K to 21.34K | |
| 14-Jun-22 8:42 PM View: | Crowther Bruce K Director | Neogenomics Inc. (NEO) | 10-Jun-22 | Grant | 15,556 | -- | -- | 31% 49.56K to 65.12K | |
| 14-Jun-22 8:41 PM View: | Tetrault Lynn A. Director | Neogenomics Inc. (NEO) | 10-Jun-22 | Grant | 15,556 | -- | -- | 40% 39.11K to 54.67K | |
| 14-Jun-22 8:42 PM View: | Hannah Alison L. Director | Neogenomics Inc. (NEO) | 10-Jun-22 | Grant | 15,556 | -- | -- | 17% 91.88K to 107.43K | |
| 02-Jun-22 6:31 PM View: | Sikri Vishal President and CCO, Inivata | Neogenomics Inc. (NEO) | 01-Jun-22 | Grant | 148,455 | -- | -- | 100% 0 to 148.46K | |
| 20-May-22 5:08 PM View: | Tetrault Lynn A. Director | Neogenomics Inc. (NEO) | 18-May-22 | Option Exercise | 3,334 | $7.27 | $24,238.20 | 9% 35.78K to 39.11K | |
| 02-May-22 5:46 PM View: | Bonello William Chief Financial Officer | Neogenomics Inc. (NEO) | 28-Apr-22 | Option Exercise | 5,727 | $7.52 | $43,067.00 | 3% 185.82K to 191.55K | |
| 04-Apr-22 7:08 PM View: | Bonello William Chief Financial Officer | Neogenomics Inc. (NEO) | 01-Apr-22 | Grant | 82,305 | -- | -- | 80% 103.52K to 185.82K | |
| 04-Apr-22 7:07 PM View: | Sholehvar David President, Clinical Services | Neogenomics Inc. (NEO) | 01-Apr-22 | Grant | 30,864 | -- | -- | 100% 0 to 30.86K | |
| 04-Apr-22 7:07 PM View: | Brown Douglas Matthew Chief Strategy Officer | Neogenomics Inc. (NEO) | 01-Apr-22 | Grant | 82,305 | -- | -- | 108% 76.38K to 158.68K | |
| 09-Mar-22 6:02 PM View: | Bonello William Chief Financial Officer | Neogenomics Inc. (NEO) | 08-Mar-22 | Option Exercise | 5,000 | $7.52 | $37,600.00 | 5% 98.52K to 103.52K | |
| 09-Mar-22 6:02 PM View: | Bonello William Chief Financial Officer | Neogenomics Inc. (NEO) | 07-Mar-22 | Planned Option Sale | 3,209 | $18.29 | $58,692.60 | (3%) 101.72K to 98.52K | |
| 03-Mar-22 7:58 PM View: | Cardoza George President & COO, Lab Ops | Neogenomics Inc. (NEO) | 02-Mar-22 | Payment of Exercise | 839 | -- | -- | (< 1%) 265.0K to 264.16K | |
| 03-Mar-22 7:57 PM View: | Bonello William Chief Financial Officer | Neogenomics Inc. (NEO) | 02-Mar-22 | Payment of Exercise | 620 | -- | -- | (< 1%) 102.34K to 101.72K | |
| 03-Mar-22 7:57 PM View: | Brown Douglas Matthew Chief Strategy Officer | Neogenomics Inc. (NEO) | 02-Mar-22 | Payment of Exercise | 867 | -- | -- | (1%) 77.25K to 76.38K | |
| 03-Mar-22 7:58 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 02-Mar-22 | Payment of Exercise | 137 | -- | -- | (< 1%) 18.77K to 18.64K | |
| 03-Mar-22 7:58 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 01-Mar-22 | Grant | 9,341 | -- | -- | 99% 9.43K to 18.77K | |
| 03-Mar-22 7:57 PM View: | Bonello William Chief Financial Officer | Neogenomics Inc. (NEO) | 01-Mar-22 | Grant | 40,869 | -- | -- | 66% 61.87K to 102.74K | |
| 03-Mar-22 7:59 PM View: | Mallon Mark Chief Executive Officer Director | Neogenomics Inc. (NEO) | 01-Mar-22 | Grant | 142,457 | -- | -- | 63% 225.59K to 368.05K | |
| 03-Mar-22 7:56 PM View: | Wallar Gina M President, Pharma Services | Neogenomics Inc. (NEO) | 01-Mar-22 | Grant | 11,677 | -- | -- | 54% 21.77K to 33.44K | |
| 03-Mar-22 7:59 PM View: | Gilbert Halley E Chief Legal Officer | Neogenomics Inc. (NEO) | 01-Mar-22 | Grant | 42,036 | -- | -- | 40% 105.36K to 147.4K |
